Orchestra Biomed Holdings Inc (OBIO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Orchestra Biomed Holdings Inc   (NASDAQ: OBIO)


Orchestra Biomed Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Orchestra Biomed Holdings Inc's ROI in the second quarter of 2026?
Orchestra Biomed Holdings Inc recorded a cumulative net loss of $-59 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -63.37%.

Within the Healthcare sector 536 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3818 to 3922.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 99.56 % 36.65 % 4 % -20.4 % -38.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 102 87 98 85 26
Return On Investment (TTM) -63.37 % -73.65 % -83.15 % -140.58 % -149.49 %
OBIO's Overall Ranking # 3922 # 3818 # 2865 # 3648 # 3412
Seq. Investment Change TTM 25.59 % 16.89 % 18.65 % 14.58 % -14 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -59 -55 -53 -75 -70

OBIO Company Profile >> Back to OBIO Roi Comparisons >> See Annual OBIO Return On Investment



Return On Investment OBIO's Ranking
Within: No.
Industry # 128
Sector # 537
Overall # 3922

Return On Investment Statistics
High Average Low
0.93 %
-55.1 %
-144.85 %
(Dec 31 2020)   (Jun 30 2025)







Financial Statements
Orchestra Biomed Holdings Inc's II. Quarter Investments $ 102 Millions OBIO's Balance sheet
Orchestra Biomed Holdings Inc's II. Quarter Income $ -24 Millions Quarterly OBIO's Income Statement
OBIO's Income by Division See OBIO's Income by Division


OBIO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 98 58 83 66 162
Y / Y Investment Growth 68.36 % -29.76 % 25.08 % -58.97 % -0.23 %
Net Income in Millions -53 -61 -49 -3 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -53.71 % -104.71 % -59.2 % -4.12 % -0.23 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OBIO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OBIO's Competitors
Subscribers only: Roi for Orchestra Biomed Holdings Inc's Suppliers
Subscribers only: Return On Investment for OBIO's Customers

Other Ratios
OBIO's Roa OBIO's Inventory Turnover Ratio OBIO's Growth Rates OBIO's Dividend Statistics
OBIO's Profitability Ratios OBIO's Asset Turnover Ratio OBIO's Dividend Growth
OBIO's Roe OBIO's Valuation Ratios OBIO's Financial Strength Ratios OBIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T21:23:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.